Miacalcin Trademark Details

Miacalcin was registered on Tuesday, October 27, 1992 and is currently owned by Novartis Ag under the registration number 1726984 . This mark is alive with a status of Registered and Renewed. The last case file activity for this mark occured 11 years ago on Friday, December 7, 2012, according to the United State Patent & Trademark Office
Word Mark Miacalcin
Status Alive Registered 800 — Registered and Renewed

Previous Owners

Sandoz Pharmaceuticals Corporation of East Hanover, NJ

View all trademarks for Sandoz Pharmaceuticals Corporation
Other Trademarks for Sandoz Pharmaceuticals Corporation

Sandoz Ag (Sandoz Lts., Sandoz S.A.)

View all trademarks for Sandoz Ag (Sandoz Lts., Sandoz S.A.)
Serial Number 74255027
Registration Number 1726984
Status Date Friday, December 7, 2012
Filing Date Friday, December 7, 2012
Registration Date Tuesday, October 27, 1992
Attorney Maury M. Tepper, III
Domestic Representative Novartis Pharmaceuticals Corporation

Correspondent

Maury M. Tepper, III
TEPPER & EYSTER, PLLC
3724 BENSON DRIVE
RALEIGH NC 27609

Case File Statements

Goods & Services pharmaceuticals used for the treatment of Paget's disease, osteoporosis and hypercalcemia

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 018
Status 6 — Active
Status Date Wednesday, April 22, 1992
First Use Anywhere Friday, June 29, 1984
First Use In Commerce Friday, June 29, 1984
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.